BB Biotech’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $74.3M | Sell |
1,142,204
-190,000
| -14% | -$12.4M | 1.87% | 17 |
|
|
2018
Q4 | $83.3M | Sell |
1,332,204
-622,392
| -32% | -$38.9M | 2.67% | 14 |
|
|
2018
Q3 | $151M | Sell |
1,954,596
-420,000
| -18% | -$32.4M | 3.99% | 9 |
|
|
2018
Q2 | $168M | Sell |
2,374,596
-300,000
| -11% | -$21.3M | 4.86% | 8 |
|
|
2018
Q1 | $202M | Sell |
2,674,596
-100,000
| -4% | -$7.54M | 5.57% | 8 |
|
|
2017
Q4 | $199M | Hold |
2,774,596
| – | – | 5.6% | 6 |
|
|
2017
Q3 | $225M | Hold |
2,774,596
| – | – | 6.22% | 4 |
|
|
2017
Q2 | $196M | Hold |
2,774,596
| – | – | 6% | 5 |
|
|
2017
Q1 | $188M | Hold |
2,774,596
| – | – | 6.16% | 4 |
|
|
2016
Q4 | $199M | Hold |
2,774,596
| – | – | 7.36% | 4 |
|
|
2016
Q3 | $220M | Hold |
2,774,596
| – | – | 7.72% | 5 |
|
|
2016
Q2 | $231M | Hold |
2,774,596
| – | – | 9.14% | 3 |
|
|
2016
Q1 | $255M | Hold |
2,774,596
| – | – | 10.13% | 4 |
|
|
2015
Q4 | $281M | Hold |
2,774,596
| – | – | 7.91% | 4 |
|
|
2015
Q3 | $272M | Buy |
2,774,596
+59,000
| +2% | +$5.79M | 8.64% | 4 |
|
|
2015
Q2 | $318M | Sell |
2,715,596
-150,000
| -5% | -$17.6M | 8.62% | 4 |
|
|
2015
Q1 | $281M | Sell |
2,865,596
-80,000
| -3% | -$7.85M | 8.38% | 4 |
|
|
2014
Q4 | $278M | Buy |
2,945,596
+150,000
| +5% | +$14.1M | 8.99% | 4 |
|
|
2014
Q3 | $298M | Sell |
2,795,596
-692,900
| -20% | -$73.8M | 12.1% | 2 |
|
|
2014
Q2 | $289M | Sell |
3,488,496
-25,000
| -0.7% | -$2.07M | 13.74% | 2 |
|
|
2014
Q1 | $249M | Sell |
3,513,496
-34,218
| -1% | -$2.42M | 12.83% | 3 |
|
|
2013
Q4 | $266M | Sell |
3,547,714
-80,000
| -2% | -$6.01M | 14.23% | 2 |
|
|
2013
Q3 | $228M | Sell |
3,627,714
-72,286
| -2% | -$4.54M | 12.41% | 3 |
|
|
2013
Q2 | $190M | Buy |
+3,700,000
| New | +$190M | 13.67% | 3 |
|